Compile Data Set for Download or QSAR
maximum 50k data
Found 520 Enz. Inhib. hit(s) with all data for entry = 85
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162561(US9687479, 41 1-[(5-chlorothiophen-2-yl)methyl]-3-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162563(US9687479, 43 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162564(US9687479, 44 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162565(US9687479, 45 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162566(US9687479, 46 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162567(US9687479, 47 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162568(US9687479, 48 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162569(US9687479, 49 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162570(US9687479, 50 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162571(US9687479, 51 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162572(US9687479, 52 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162573(US9687479, 53 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162575(US9687479, 55 1-benzyl-3-1-[(2-chlorophenyl)carbon...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162576(US9687479, 56 2-[3-(5-[(5-chlorothiophen-2-yl)meth...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162586(US9687479, 66 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162587(US9687479, 67 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162589(US9687479, 69 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162590(US9687479, 70 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162591(US9687479, 71 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162592(US9687479, 72 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162593(US9687479, 73 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162594(US9687479, 74 3-(5-[(4-fluorophenyl)methyl]amino-1...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162595(US9687479, 75 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162596(US9687479, 76 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162597(US9687479, 77 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162598(US9687479, 78 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162599(US9687479, 79 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162600(US9687479, 80 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162601(US9687479, 81 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162602(US9687479, 82 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162603(US9687479, 83 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162603(US9687479, 83 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162605(US9687479, 85 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162606(US9687479, 86 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162607(US9687479, 87 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162608(US9687479, 88 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162609(US9687479, 89 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162610(US9687479, 90 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162611(US9687479, 91 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162612(US9687479, 92 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162613(US9687479, 93 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162614(US9687479, 94 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162615(US9687479, 95 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM163508(US9687479, 22 N-[(5-chlorothiophen-2-yl)methyl]-1-...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162616(US9687479, 96 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162617(US9687479, 97 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162618(US9687479, 98 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162619(US9687479, 99 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162620(US9687479, 100 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Verseon

US Patent
LigandPNGBDBM162621(US9687479, 101 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 520 total ) | Next | Last >>
Jump to: